Chemistry:Homarylamine

From HandWiki
Short description: Chemical compound
Homarylamine
Methylenedioxymethylphenethylamine.svg
Clinical data
Other names1,3-benzodioxolyl-N-methyl-5-ethanamine;
3,4-methylenedioxy-N-methyl-2-phenylethylamine;
Norlobivine
Routes of
administration
Various
Legal status
Legal status
  • US-SCHEDULE I DRUG as Positional isomer of MDA
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC10H13NO2
Molar mass179.219 g·mol−1
3D model (JSmol)
  (verify)

Homarylamine (INN;[1] also known as 3,4-methylenedioxy-N-methylphenethylamine and MDMPEA) is an antitussive (anti-cough) drug[2] which was patented in 1956 by Merck & Co.,[3] but has never been used medically as such.

Chemically it is a substituted phenethylamine. It is the N-methylated analog of methylenedioxyphenethylamine (MDPEA). It is a schedule I drug in the USA as a positional isomer of MDA.

Methylenedioxyphenethylamine (MDPEA) for comparison

Reactions

Reaction of homoarylamine with formaldehyde gives hydrastinine.

See also

  • Hydrastine, an alkaloid derivative of homarylamine

References

  1. "International Non-Proprietary Names for Pharmaceutical Preparations". Chronicle of the World Health Organization 12 (3). 1958. https://www.who.int/medicines/publications/druginformation/innlists/PL06.pdf. 
  2. "Experimental Investigation of Nine Antitussive Drugs". Journal of Pharmaceutical Sciences 50 (3): 216–221. March 1961. doi:10.1002/jps.2600500309. 
  3. U.S. Patent 2,820,739